Address And Details

255 Liberty Street , New York, NY 10286
Fund Manager John Flahive
Manager Tenure 9 Years 6 Months

Strategy And Objective

The fund seeks total return (consisting of capital appreciation and current income). To pursue its goal, the fund normally invests at least 80% of its net assets, plus any borrowings for investment purposes, in corporate bonds. BNYM Investment Adviser uses a disciplined process to select bonds and manage risk. The process includes computer modeling and scenario testing of possible changes in market conditions. BNYM Investment Adviser will use other techniques in an attempt to manage market risk and duration. BNYM Investment Adviser actively manages the fund's bond market and maturity exposure and credit profile. The fund normally invests at least 80% of its assets in bonds rated investment grade (i.e., Baa/BBB or higher) at the time of purchase or, if unrated, deemed of comparable quality by BNYM Investment Adviser, with at least 65% of such investment grade bonds issued by corporations or the U.S. government or its agencies. Generally, the average effective duration of the fund's portfolio will not exceed eight years. The fund may invest in individual bonds of any duration. There are no restrictions on the dollar-weighted average maturity of the fund's portfolio or on the maturities of the individual bonds the fund may purchase. A bond's maturity is the length of time until the principal must be fully repaid with interest. Dollar-weighted average maturity is an average of the stated maturities of the securities held by the fund, based on their dollar-weighted proportions in the fund. Duration is an indication of an investment's "interest rate risk," or how sensitive a bond or the fund's portfolio may be to changes in interest rates. In selecting corporate bonds for investment, the fund's portfolio managers analyze fundamental metrics, including the issuer's cash flow, leverage and operating margins, as well as its business strategy and operating performance, and macro economic factors. The fund typically sells a security when the portfolio managers believe that there has been a negative change in the credit quality of the issuer or has identified a more attractive opportunity or when the portfolio managers seek to manage the fund's duration or tax position or to provide liquidity to meet shareholder redemptions.

Net Asset Value

as of 4:52 PM ET 09/17/2021

Performance

  • 1 Week
  • -0.07%
  • 1 Month
  • -0.22%
  • 3 Months
  • +0.15%
  • 1 Yr Return
  • +0.36%
  • 5 Yr Return
  • +5.75%

Equity Sector Breakdown

ConsumerDurables n/a
Energy n/a
Finance n/a
Health n/a
IndustrialCyclical n/a
NonDurables n/a
RetailTrade n/a
Services n/a
Technology n/a
Utilities n/a

Asset Allocation

Asset Type % Of Allocation
Bonds 96.53%
Cash 3.98%
Preferred 1.52%
Stocks 0.00%
Convertible 0.00%
ForeignStocks 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Other -2.04%
Total Net Assets 756.03 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha 1.32 1.71 n/a
Beta 1.08 1.02 n/a
R Squared 0.34 0.39 n/a
Std Deviation 6.44 5.26 n/a
Sharpe Ratio 0.95 0.73 n/a

Purchase Information

as of 4:55 PM ET 09/16/2021
Minimum Initial $10000
Minimum Additional $100
Minimum Initial IRA $0

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 05/31/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 05/31/2021
1 Year
  • +4.29%
  • +7.80%
+4.29% +7.80%
3 Year
  • +7.05%
  • +6.88%
+7.05% +6.88%
10 Year
  • n/a
  • n/a
n/a n/a
Life Of Fund
  • +4.57%
  • +4.53%
+4.57% +4.53%

Top 10 Holdings

Symbol Company Name % Of Assets
n/a

Recent Articles from TheStreet

Pfizer vaccine Lead

Pfizer Says Its COVID Vaccine Safe For Children 5 to 11 In Lower Doses

"These trial results provide a strong foundation for seeking authorization of our vaccine for children 5 to 11 years old, and we plan to submit them to the FDA and other regulators with urgency," said Pfizer CEO Albert Bourla.

Wall Street NYSE Lead

Dow Futures Slump As China Evergrande, Growth Worries Rattle Global Stocks

The potential collapse of indebted property developer China Evergrande has added to market angst ahead of what could be a crucial meeting of the Federal Reserve later this week.

Wall Street Lead

Stocks Slump, Evergrande Plunges, Canadians Vote, Ted Lasso Charms - 5 Things You Must Know

Stock futures slump on China, growth risk; China Evergrande plunges as bond payments loom; FDA panel awaits more data on COVID; Canadians got to the polls and Ted Lasso and The Crown sweep top Emmy awards.

Elon Musk Starlink Lead

SpaceX CEO Elon Musk Says Starlink Exits Beta Next Month

SpaceX CEO Elon Musk says the company’s Starlink high-speed internet service will come out of beta testing next month.

Wall Street Lead

Cramer: Using Short-Term Moves to Tweak Your Portfolio

Whether the news is good or bad, you can take advantage of it if you understand why you're involved in a stock in the first place.

10. Chemical & petrochemical pharma sh

Jensen: These Three Healthcare Stocks Are Worth a Look

Just because we're in the market's worst month of the year doesn't mean there aren't good investments available.

18. Apple Inc. (AAPL)

Parus Files Second Patent Infringement Lawsuit Against Apple

Parus files a second patent infringement lawsuit against Apple, alleging it infringed on its patents for voice-browsing and device control technology.

12. Software engineer

Business Software Provider AvidXchange Files for IPO

Accounts payable software provider AvidXchange on Friday filed for a initial public offering.

9/11 Lead

Cramer’s Recollections of 9/11

A beautiful day in New York City, Then the Unimaginable

Hong Kong Stocks Slump On Tech Sector Worries As US Official Signals Flaws In China Trade Deal

Intraday Reversals Signal Struggles for Market

But James "Rev Shark" Deporre says the trading action is both normal, and appropriate for September, and he's been adding some names to his portfolio.